King Wealth Gilead Sciences, Inc. Transaction History

King Wealth

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$62.1 - $78.08 $167,918 - $211,128	-2,704 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$72.34 - $84.0 $289 - $336	4 Added 0.15%	2,704 $208,000
Q1 2020 May 13, 2020	SELL	$62.63 - $80.22 $2.01 Million - $2.57 Million	-32,030 Reduced 92.23%	2,700 $202,000
Q4 2019 Feb 13, 2020	SELL	$61.62 - $67.78 $36,725 - $40,396	-596 Reduced 1.69%	34,730 $2.26 Million
Q3 2019 Nov 13, 2019	BUY	$62.51 - $69.0 $361,307 - $398,820	5,780 Added 19.56%	35,326 $2.24 Million
Q2 2019 Aug 13, 2019	SELL	$61.87 - $69.38 $187,466 - $210,221	-3,030 Reduced 9.3%	29,546 $2 Million
Q1 2019 May 13, 2019	BUY	$62.53 - $70.05 $1.15 Million - $1.29 Million	18,365 Added 129.23%	32,576 $2.12 Million
Q4 2018 Feb 14, 2019	BUY	$60.54 - $79.0 $860,333 - $1.12 Million	14,211 New	14,211 $889,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of King Wealth, based on Form 13F filings with the SEC.

Stay updated on King Wealth with notifications on news.